It has been described that conformation-dependent tau antibodies distinguish pathological tau in AD from other tauopathies but do not distinguish AD from PART [62], and tau seeding activity from the transentorhinal/entorhinal cortices (where tau pathology starts early) does not differ between AD and PART [63]. This evidence concerns the gene MAPT and Alzheimer disease.